It has previously been shown that monocytes from either diabetes mellitus or hypercholesterolemic patients exhibit defective chemotactic responses to individual growth factors ex vivo including VEGF-A or MCP-1 [14–17, 20, 32]. The gene discussed is VEGFA; the disease is diabetes mellitus.